HGB-206

FDA scuttles bluebird's accelerated plans for sickle cell gene therapy, as higher CMC bar forces 1-year delay
Endpoints
Thu, 11/5/20 - 11:05 am
Bluebird Bio
FDA
sickle cell disease
gene therapy
HGB-206
Bluebird’s tweaked sickle cell gene therapy clears early test
Fierce Biotech
Wed, 11/1/17 - 06:42 pm
Bluebird Bio
sickle cell disease
gene therapy
HGB-206
3 Clinical Trials to Watch As Bluebird Bio Rounds Out 2015
Motley Fool
Mon, 09/14/15 - 08:28 am
clinical trials
Bluebird Bio
HGB-205
HGB-206
HGB-204
sickle cell disease
beta-thalassemia